JLK

JLK Current Liabilities

The Current Liabilities of JLK (322510.KQ) as of Nov 3, 2026 is 194.49 M KRW. In the previous year, Current Liabilities was 7.74 B KRW — a change of -97.49% (lower).

Current Liabilities

194.49 MKRW

YoY

-97.49%

Last updated:

Current Liabilities of JLK is 2025 194.49 M KRW. Current Liabilities of JLK was 2024 7.74 B KRW. It decreases by -97.49% lower compared to the previous year.

The JLK Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
1.10 B KRW
Jan 1, 2019
725.61 M KRW
Jan 1, 2020
2.27 B KRW
Jan 1, 2021
1.09 B KRW
Jan 1, 2022
1.08 B KRW
Jan 1, 2023
5.48 B KRW
Jan 1, 2024
7.74 B KRW
Jan 1, 2025
194.49 M KRW
The JLK Current Liabilities history
YEARCurrent LiabilitiesYoY
194.49 MKRW-97.49%
7.74 BKRW+41.24%
5.48 BKRW+405.97%
1.08 BKRW-0.81%
1.09 BKRW-52.00%
2.27 BKRW+213.51%
725.61 MKRW-34.10%
1.10 BKRW-22.90%
1.43 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JLK Stock analysis

What does JLK do? JLK, Inc. generates revenue through AI medical analysis solutions, AI industry and security analysis solutions, and AI medical diagnostic platforms. The company's products include AI medical systems, AI quantitative analysis platforms, and AI remote platforms, which are sold to healthcare providers and medical institutions. The primary customer segments are hospitals and clinics seeking advanced diagnostic tools for brain disease detection. Revenue streams are derived from software licensing and subscription services for these AI-driven diagnostic systems. JLK, Inc. focuses on developing AI-based data-driven diagnostic systems specifically for brain disease detection. The company's AI medical diagnostic platforms are designed to provide accurate and efficient analysis for medical professionals. These platforms are part of the broader suite of AI medical analysis solutions that include AI quantitative analysis and AI remote platforms. The firm's target market includes healthcare facilities requiring cutting-edge technology for neurological diagnostics. The company's software products, such as AI medical systems and AI quantitative analysis platforms, are marketed to healthcare institutions for integration into their diagnostic workflows. Revenue is primarily generated through licensing agreements and recurring subscription fees for access to the AI-driven diagnostic tools. These solutions are positioned as essential for modern healthcare providers aiming to enhance diagnostic accuracy and patient outcomes in brain disease detection. JLK is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JLK stock

Current Liabilities of JLK is 194.49 M KRW in 2025.

Current Liabilities of JLK changed from 7.74 B KRW to 194.49 M KRW, representing a -97.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities JLK since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's JLK historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — JLK

All Key Metrics — JLK